NCT00964054

Brief Summary

This pilot study may yield important research findings on how to adapt exercise treatment for depression among adolescents. Potential public health benefits from this study include a reduction of adolescent depression and problems associated with untreated depression in young adults including suicide, substance abuse, cigarette smoking, teen pregnancy, impaired psychosocial functioning and school failure. In addition, because this study prescribes physical activity as a treatment for depression, additional public health benefits may include a reduction in chronic diseases such as obesity, diabetes and heart disease, all of which are associated with sedentary behavior.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Sep 2012

Shorter than P25 for phase_1

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 24, 2009

Completed
3 years until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
Last Updated

March 14, 2013

Status Verified

April 1, 2012

Enrollment Period

4 months

First QC Date

August 20, 2009

Last Update Submit

March 13, 2013

Conditions

Keywords

adolescentsexercisedepressiondose responsepilot study

Outcome Measures

Primary Outcomes (1)

  • Child Depression Rating Scale-Revised (CDRS-R)

    repeated measures, 12-weeks

Secondary Outcomes (3)

  • Beck Depression Inventory (BDI)

    repeated measures, 12 weeks

  • The Multidimensional Anxiety Scale for Children (MASC)

    baseline and 12 weeks

  • Adolescent Stress Questionnaire (ASQ)

    baseline and 12 weeks

Study Arms (2)

Public Health Dose of Exercise (PHD)

EXPERIMENTAL

17.5 kcal per kilogram per week

Other: Public Health Dose of Exercise (PHD)

Low Dose Exercise (LD)

ACTIVE COMPARATOR

7.0 kcal per kilogram per week

Other: Low Dose Exercise (LD)

Interventions

17.5 kcal per kilogram per week

Also known as: Exercise, Physical Activity
Public Health Dose of Exercise (PHD)

7.0 kcal per kilogram per week

Also known as: Exercise, Physical Activity
Low Dose Exercise (LD)

Eligibility Criteria

Age12 Years - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Primary Diagnosis of DSM-IV Major Depression Disorder (MDD)
  • Child Depression Rating Scale Revised \> or = 40 at final screen
  • to 21 years of age
  • On a stable dose of antidepressants or ADHD medication only
  • Physically capable of exercise according to AHA and ACSM standards
  • Able to pass illicit drug screen
  • Perform \< 20 minutes per day of moderate to vigorous physical activity
  • Parental consent and participant assent
  • Denver metropolitan area including Jefferson county

You may not qualify if:

  • Chronic disease that would limit exercise
  • Other psychiatric illness
  • Suicidal or homicidal
  • Concurrent psychotherapy
  • Two previous failed SSRI trials or a failed trial of CBT
  • Current pregnancy or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depressive DisorderMotor ActivityDepression

Interventions

Exercise

Condition Hierarchy (Ancestors)

Mood DisordersMental DisordersBehaviorBehavioral Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Andrea L Dunn, PhD

    Klein Buendel, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2009

First Posted

August 24, 2009

Study Start

September 1, 2012

Primary Completion

January 1, 2013

Study Completion

February 1, 2013

Last Updated

March 14, 2013

Record last verified: 2012-04